title: [Small cell carcinoma of the prostate: a case report].
abstract: Pure small cells carcinoma of the prostate is a rare tumour with a pejorative forecast. We report a case of neuroendocrine small cells carcinoma developed at a 68 years old patient. This tumour expressed a positive marking immunohistochimic with chromogranin A, the rate of PSA was on the other hand normal (2.9 ng/ml). The patient was treated by chemotherapy associating etoposide and cisplatinium and external radiotherapy. He is deceased 4 months afterwards.
authors.affiliation: Clinique urologique A, hôpital Avicenne, CHU Rabat-Salé, Maroc.
authors.forename: A
authors.initials: A
authors.lastname: Benchekroun
authors.forename: Y
authors.initials: Y
authors.lastname: Nouini
authors.forename: M
authors.initials: M
authors.lastname: Zannoud
authors.forename: el Hassan
authors.initials: el H
authors.lastname: Kasmaoui
authors.forename: M
authors.initials: M
authors.lastname: Jira
authors.forename: A
authors.initials: A
authors.lastname: Iken
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D018714:Radiotherapy, Adjuvant
chemical_list: D005047:Etoposide; D002945:Cisplatin